About this trial
This study explores whether adding early nurse-led and psychological support after the diagnosis of retinitis pigmentosa (RP) can improve patient experience and emotional well-being. RP is a rare, progressive eye disease often diagnosed after a long and difficult process, and receiving the diagnosis can be emotionally distressing.
Eighty newly diagnosed adults will be randomly assigned to either usual care or an enhanced pathway that includes early follow-up with a nurse, structured emotional monitoring, and a psychologist visit at six months.
The study aims to determine if this structured support improves patient satisfaction and reduces anxiety and depression compared with standard care.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosed with retinitis pigmentosa (RP) and followed at the Quinze-Vingts Rare Eye Disease Center, with diagnosis made after the project begins
Aged 18 to 65 years
Male or female
French-speaking
Disqualifiers
Pregnant women
Participants enrolled in a therapeutic clinical trial within the past 12 months
Individuals deprived of liberty by judicial or administrative decision
Adults under legal protection or unable to provide informed consent
Trial design
Parallel
Treatments tested in this trial
Enhanced post-diagnostic support
BehavioralNurse-led and psychologist consultation
Usual Care
BehavioralStandard ophthalmologist consultation with optional psychologist consultation
Treatment groups
Trial outcomes
Primary outcomes
Patient Satisfaction via PREM at 12 months
Difference in patient satisfaction via PREM (Patient Reported Experience Measure) at 12 months between the two arms. Items were rated on a 5-point Likert scale ranging from 1 (extremely worse than expected) to 5 (better than expected). Higher scores indicate a better perceived quality of care and psychological support.
Secondary outcomes
Psychological impact after post-diagnostic support via HADS
Evaluation of the psychological impact of the enhanced post-diagnostic care. Longitudinal assessment of emotional well-being in the experimental group will be performed using the Hospital Anxiety and Depression Scale (HADS) at three key time points. Each subscale (anxiety and depression) ranges from 0 to 21, with higher scores indicating greater symptom severity (worse outcome).
Feasibility and staff experience of implementing enhanced post-diagnostic support via RETEX and observation log
Nursing staff will complete a RETEX (Retour d'Expérience) questionnaire to assess the feasibility of the enhanced post-diagnostic care. The questionnaire evaluates challenges such as physician presence, adequacy of tools and setting, respect for patient privacy, communication with other staff, and consultation duration. The RETEX questionnaire consists of 11 dichotomous (Yes/No) items completed by nursing staff. Total score ranges from 0 to 11. Higher scores indicate greater perceived emotional and/or organizational burden, whereas lower scores indicate better feasibility and professional comfort.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.